Fig. 4From: Personalized pancreatic cancer therapy: from the perspective of mRNA vaccineTumor evolution in pancreatic cancer therapy. Pancreatic cancer is characterized by prevalent intra-tumoral heterogeneity and composed of therapeutic sensitive cells, genetically resistant cells, and epigenetically persister cells. Therapeutic stress in pancreatic cancer causes the transformation of tumor characteristics, leading to acquired resistanceBack to article page